What does client service mean to us? It means developing custom relationships, sharing our technical expertise, and providing practical solutions delivered by pragmatic IP professionals who are easy to work with. We carefully structure our teams to ensure that we have the right blend of knowledge and experience to meet the unique needs of each client. Regardless of the industry in which you operate, our patent, design and trade mark specialists will quickly understand your business and your IP issues, with the addition of significant value right from the start of the working relationship.
EXPERTISE
"They are a very bright, thoughtful bunch and are easy to work with. Their advice is timely, comprehensive, commercial and very sound."
Client quote, Chambers and PartnersWe are a people business. To deliver exceptional service to our clients, we seek individuals with a combination of talent, commercial awareness, and integrity. Our clients depend on our expertise – but they also appreciate our individual personalities and our collaborative way of working. Within a supportive working environment, we empower our staff to strive for excellence. We recognise that when our employees reach their full potential, our firm also succeeds.
CAREERSThe EPO Enlarged Board of Appeal will consider key questions in G 1/26 on claim interpretation, the role of the description and the assessment of added subject matter under Article 123(2) EPC.
Boult has again been ranked as Gold in the IAM’s Patent 1000 for patent prosecution in the UK and before the European Patent Office (EPO).
As the UK trade mark register turns 150, a public vote names the nation’s most iconic brands, underscoring the lasting importance of robust trade mark protection.
The UPC’s PMAC has launched its Case Management System, enabling rapid, confidential ADR for patent disputes with global reach and new strategic options for litigants.
Boult’s guide to IP rights and exclusivity for pharma and biotech in Europe.
Discover how patent protection plays a fundamental role in incentivising and rewarding research and development in the pharmaceutical and biotechnology sectors.
TRENDING TOPICS
